You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 11, November 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Transgenic Models of Skin Diseases

Joseph A. Rothnagel, PhD; David A. Greenhalgh, PhD; Xiao-Jing Wang, MD, PhD; Klaus Sellheyer, MD; Jackie R. Bickenbach, PhD; Andrea M. Dominey, MD; Dennis R. Roop, PhD

Arch Dermatol. 1993;129(11):1430-1436.


Abstract

Background
Transgenic animals have greatly enhanced our understanding of the contribution of various structural and regulatory components to epidermal biology. The expression of mutant versions of these components in the epidermis of transgenic mice has generated animal models of specific human skin diseases.

Observations.
The expression of mutant keratin genes has produced animal models of epidermolysis bullosa simplex and epidermolytic hyperkeratosis and, in doing so, has focused attention on the genetics of keratins in these and other skin disorders. Similarly, the generation of mice overexpressing growth factors and/or oncogenes, exclusively in the epidermis, has identified the role of these factors in normal skin and produced models of disease states where the regulation of these factors is perturbed.

Conclusions
These models of keratin disorders and other diseases not only enable the determination of the cause of these disorders, but also allow evaluation of novel therapeutic techniques for the amelioration of these skin diseases.

(Arch Dermatol. 1993;129:1430-1436)



Author Affiliations

From the Departments of Cell Biology (Drs Rothnagel, Greenhalgh, Wang, Sellheyer, Bickenbach, and Roop) and Dermatology (Drs Rothnagel, Greenhalgh, Dominey, and Roop), Baylor College of Medicine, Houston, Tex.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Functional Diversity of Epidermal Keratins Revealed by the Partial Rescue of the Keratin 14 Null Phenotype by Keratin 16
Paladini and Coulombe
JCB 1999;146:1185-1201.
ABSTRACT | FULL TEXT  

Directed Expression of Keratin 16 to the Progenitor Basal Cells of Transgenic Mouse Skin Delays Skin Maturation
Paladini and Coulombe
JCB 1998;142:1035-1051.
ABSTRACT | FULL TEXT  

Out of balance: consequences of a partial keratin 10 knockout
Reichelt et al.
J. Cell Sci. 1997;110:2175-2186.
ABSTRACT  

A transgenic mouse model with an inducible skin blistering disease phenotype
Takahashi and Coulombe
Proc. Natl. Acad. Sci. USA 1996;93:14776-14781.
ABSTRACT | FULL TEXT  

Enamel Mineral Composition of Normal and Cystic Fibrosis Transgenic Mice
Wright et al.
ADR 1996;10:270-275.
ABSTRACT  

Disruption of intermediate filament organization leads to structural defects at the intersomite junction in Xenopus myotomal muscle
Cary and Klymkowsky
Development 1995;121:1041-1052.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.